Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery
Clinical trial NCT02961062 · COMPLETED
Trial details
- NCT number
- NCT02961062
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-01-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.